ACESOT-1051 trial evaluating WEE1 kinase inhibitor APR-1051 now enrolling patients in Cohort 5; open label safety and efficacy data expected H2 ...

Berubicin showed clinically relevant outcomes comparable to Lomustine across multiple endpoints, but not a statistically significant difference in overall survival, the primary endpoint.The safety pro ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo ...

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...

John "Chip" Scarlett, who as chairman, president and CEO repositioned Geron Corp. and guided the company to its first drug ...

For the pharmaceutical company, literacy is needed in specialized and core job skills, including research, supply chain, and finance. Then there's fluency in AI technology. "There are so many ways ...

(RTTNews) - Eli Lilly and Company (LLY) Wednesday announced plans to bolster its domestic medicine production across therapeutic areas by building four new pharmaceutical manufacturing sites in ...